Burhan Ferhanoğlu

2.1k total citations
78 papers, 1.1k citations indexed

About

Burhan Ferhanoğlu is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Burhan Ferhanoğlu has authored 78 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 28 papers in Oncology and 24 papers in Genetics. Recurrent topics in Burhan Ferhanoğlu's work include Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Viral-associated cancers and disorders (12 papers). Burhan Ferhanoğlu is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Viral-associated cancers and disorders (12 papers). Burhan Ferhanoğlu collaborates with scholars based in Türkiye, United States and Australia. Burhan Ferhanoğlu's co-authors include Zafer Başlar, Alissa Tsai, Radhika Sanduja, Kenneth K. Wu, D. S. Loose-Mitchell, Şeniz Öngören, Mustafa Çeti̇ner, Muhlis Cem Ar, Lisa Lowry and Nükhet Tüzüner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Burhan Ferhanoğlu

75 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burhan Ferhanoğlu Türkiye 14 505 453 262 212 118 78 1.1k
Senji Kasahara Japan 21 425 0.8× 434 1.0× 171 0.7× 236 1.1× 120 1.0× 85 1.3k
Ru Feng China 17 373 0.7× 319 0.7× 273 1.0× 231 1.1× 67 0.6× 93 998
R. Arranz Spain 21 717 1.4× 861 1.9× 264 1.0× 429 2.0× 146 1.2× 42 1.5k
Chung‐Che Chang United States 20 329 0.7× 371 0.8× 210 0.8× 190 0.9× 96 0.8× 43 1.0k
Pam McKay United Kingdom 21 763 1.5× 443 1.0× 524 2.0× 355 1.7× 389 3.3× 77 1.4k
Styliani Kokoris Greece 19 271 0.5× 214 0.5× 210 0.8× 213 1.0× 87 0.7× 55 899
G. L. Phillips Canada 20 283 0.6× 507 1.1× 325 1.2× 931 4.4× 145 1.2× 47 1.6k
Michela Ribersani Italy 13 344 0.7× 290 0.6× 206 0.8× 213 1.0× 83 0.7× 32 1.0k
Driss Chaoui France 16 161 0.3× 478 1.1× 196 0.7× 324 1.5× 96 0.8× 29 1.1k
Hung Chang Taiwan 18 254 0.5× 252 0.6× 142 0.5× 235 1.1× 108 0.9× 98 1.0k

Countries citing papers authored by Burhan Ferhanoğlu

Since Specialization
Citations

This map shows the geographic impact of Burhan Ferhanoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burhan Ferhanoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burhan Ferhanoğlu more than expected).

Fields of papers citing papers by Burhan Ferhanoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burhan Ferhanoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burhan Ferhanoğlu. The network helps show where Burhan Ferhanoğlu may publish in the future.

Co-authorship network of co-authors of Burhan Ferhanoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Burhan Ferhanoğlu. A scholar is included among the top collaborators of Burhan Ferhanoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burhan Ferhanoğlu. Burhan Ferhanoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wilson, William, Laura Clifton‐Hadley, Wendi Qian, et al.. (2025). Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial. The Lancet Haematology. 12(5). e335–e345. 2 indexed citations
3.
Ferhanoğlu, Burhan, Tae Min Kim, Amado Karduss, et al.. (2022). Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study. Leukemia & lymphoma. 63(14). 3317–3330. 2 indexed citations
4.
Dal, Mehmet Sinan, Olga Meltem Akay, Özgür Mehtap, et al.. (2021). Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. Journal of Chemotherapy. 34(3). 190–198. 8 indexed citations
5.
Tokat, Fatma, et al.. (2020). IRF4-Rearranged Large B-Cell Lymphoma on Waldeyer’s Ring: A Case Report. Turkish Journal of Hematology. 37(4). 292–294. 2 indexed citations
6.
Salihoğlu, Ayşe, Teoman Soysal, Ìhsan Karadoǧan, et al.. (2019). Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience. Annals of Hematology. 99(2). 301–307. 5 indexed citations
7.
8.
Eşkazan, Ahmet Emre, Mahir Cengız, Muhlis Cem Ar, et al.. (2016). Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Journal of Clinical Pathology. 69(9). 810–816. 3 indexed citations
9.
Tecimer, Tülay, et al.. (2016). Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report. Indian Journal of Hematology and Blood Transfusion. 32(S1). 178–180. 2 indexed citations
10.
Yemişen, Mücahit, İ̇lker İnanç Balkan, Ayşe Salihoğlu, et al.. (2016). The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients. Turkish Journal of Hematology. 33(3). 216–222. 13 indexed citations
11.
Offner, Fritz, Olga Samoilova, Evgenii A. Osmanov, et al.. (2015). Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL. Blood. 126(16). 1893–1901. 98 indexed citations
12.
Salihoğlu, Ayşe, Tuğrul Elverdi, Ìhsan Karadoǧan, et al.. (2014). Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Annals of Hematology. 94(3). 415–420. 22 indexed citations
13.
Çetin, Güven, Ahmet Emre Eşkazan, Muhlis Cem Ar, et al.. (2014). Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options. Turkish Journal of Hematology. 31(4). 374–380. 1 indexed citations
14.
Eşkazan, Ahmet Emre, Şeniz Öngören, Muhlis Cem Ar, et al.. (2011). Essential Thrombocythemia and Multiple Myeloma: Two Rare Diseases in One Patient. Clinical Lymphoma Myeloma & Leukemia. 11(5). 442–445. 9 indexed citations
15.
Ar, Muhlis Cem, Zafer Başlar, Teoman Soysal, et al.. (2009). The Effect of ZAP-70 Expression on Disease Progression in Early-Stage (Binet A) B-CLL Patients. Balkan Medical Journal. 2009(4). 317–321. 1 indexed citations
16.
Öngören, Şeniz, Muhlis Cem Ar, Ahmet Emre Eşkazan, et al.. (2009). Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(2). 321–330. 1 indexed citations
17.
Ng, Özden Hatırnaz, Muhlis Cem Ar, Cemaliye Boylu Akyerli, et al.. (2007). The SOCS‐1 gene methylation in chronic myeloid leukemia patients. American Journal of Hematology. 82(8). 729–730. 29 indexed citations
18.
Sili, Uluhan, et al.. (2007). Candida krusei Arthritis in a Patient with Hematologic Malignancy: Successful Treatment with Voriconazole. Clinical Infectious Diseases. 45(7). 897–898. 14 indexed citations
19.
Pamuk, Ömer Nurı, Zafer Başlar, Şeniz Öngören, et al.. (2002). Overview of 321 patients with idiopathic thrombocytopenic purpura. Annals of Hematology. 81(8). 436–440. 77 indexed citations
20.
Ferhanoğlu, Burhan. (1989). Hiperkoagülabilite Ve Tromboz. Turkiye Klinikleri Tip Bilimleri Dergisi. 9(5). 333–341. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Senji Kasahara Breakdown of academic impact, for papers by Ru Feng Breakdown of academic impact, for papers by R. Arranz Breakdown of academic impact, for papers by Chung‐Che Chang Breakdown of academic impact, for papers by Pam McKay Breakdown of academic impact, for papers by Styliani Kokoris Breakdown of academic impact, for papers by G. L. Phillips Breakdown of academic impact, for papers by Michela Ribersani Breakdown of academic impact, for papers by Driss Chaoui Breakdown of academic impact, for papers by Hung Chang
Rankless by CCL
2026